chrisvoncsefalvay/vaers-outcomes huggingface dataset:
aches and felt like something was taking over her body and she was going to die; Hands locked up, knuckles could not straighten; Painful when knuckles straightened; Felt red and hot, than felt cold; she could not move, and could not get up; aches: in her head, neck, face, arms, hands, neck, shoulder, and back; Felt red and hot, than felt cold; Could not sleep; Fever; aches: in her head, neck, face, arms, hands, neck, shoulder, and back; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 67 year-old female patient received bnt162b2 (BNT162B2), administration date 28Dec2021 (Batch/Lot number: unknown) at the age of 67 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: NEAR DEATH EXPERIENCE (medically significant) with onset Dec2021, outcome "unknown", described as "aches and felt like something was taking over her body and she was going to die"; HAND DEFORMITY (non-serious) with onset Dec2021, outcome "unknown", described as "Hands locked up, knuckles could not straighten"; PAIN (non-serious) with onset Dec2021, outcome "unknown", described as "Painful when knuckles straightened"; FEELING OF BODY TEMPERATURE CHANGE (non-serious), ERYTHEMA (non-serious) all with onset Dec2021, outcome "unknown" and all described as "Felt red and hot, than felt cold"; MOVEMENT DISORDER (non-serious) with onset Dec2021, outcome "unknown", described as "she could not move, and could not get up"; BACK PAIN (non-serious), HEADACHE (non-serious) all with onset Dec2021, outcome "unknown" and all described as "aches: in her head, neck, face, arms, hands, neck, shoulder, and back"; INSOMNIA (non-serious) with onset Dec2021, outcome "unknown", described as "Could not sleep"; PYREXIA (non-serious) with onset Dec2021, outcome "unknown", described as "Fever". Clinical course: The patient was fine and she has not missed work in 17years, patient do not want to take next dose. The patient experienced painful when knuckles straightened. Reporter seriousness for hands locked up, knuckles could not straighten, Painful when knuckles straightened, Aches, Could not sleep, Does not want to take second shot, Fever, Felt red and hot, than felt cold: unspecified.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Body Aches the following day and night like from a fever, but normal temperature.   Redness, swelling, and touch-sensitivity  in 1" diameter circle around injection site and continued aching in injected shoulder area. Sensitivity around injected shoulder's underarm area.
Severe headache, tiredness, fatigue, body aches and pains, fever, chills, sore arm
6-8hr p/vax pt devel h/a, muscle aches, marked fatigue & tender areas in various parts of body;later devel nausea, vomiting & diarrhea;
numbness of the face; This is a spontaneous report from a contactable consumer. A patient of an unspecified gender and age received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number was not reported) via an unspecified route on unspecified date as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On unspecified date, the patient experienced numbness of his right ear and right side of the face. Patient also had nose bleeding and it has been resolved now. Reporter stated that his cousin also had numbness of the face after the 1st dose and was advised by his doctor not to get mRNA vaccines. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
This spontaneous report was received from a registered nurse concerning a patient of unknown age and gender. Medical history and concurrent conditions were not reported. On 08-SEP-2014, the patient was vaccinated with a dose of (Oka/Merck) VARIVAX (dose number and route were not reported), 0.5 ml, lot # K005182, expiration date 10-APR-2014 for vaccination. Co-suspect and concomitant therapies were not reported. The registered nurse reported the 26 patient s received doses of (Oka/Merck) VARIVAX (from lot # K005182, expiration date 10-APR-201 only) that were improperly stored. No adverse effect reported for any of the patients. This is one (1) of twenty seven (27) reports from the same reporter. Additional information has been requested.
Last dose of the Post Exposure Series of Rabies given 14 days ago, client continues to c/o vertigo. Onset was noted after 4th injection. Sx not better but not going away.
Somewhat fatigued; Very, very sore arm; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Somewhat fatigued) and MYALGIA (Very, very sore arm) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016B21A and 022M20A) for COVID-19 vaccination.     Concurrent medical conditions included Asthma.   On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 31-Mar-2021, the patient experienced FATIGUE (Somewhat fatigued) and MYALGIA (Very, very sore arm). The patient was treated with PREDNISONE for Asthma, at an unspecified dose and frequency. On 01-Apr-2021, FATIGUE (Somewhat fatigued) and MYALGIA (Very, very sore arm) had resolved.            No Concomitant medication was reported.   This case was linked to MOD-2021-348409, MOD-2021-348441 (Patient Link).
Patient developed a red to purple blotchy rash on entire lower body a few days after vaccination and lasted a little less than 2 weeks.
vaccine that underwent temperature excursions could have been administered to patient; No adverse event; vaccine that underwent temperature excursions could have been administered to patient; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (vaccine that underwent temperature excursions could have been administered to patient), POOR QUALITY PRODUCT ADMINISTERED (vaccine that underwent temperature excursions could have been administered to patient) and NO ADVERSE EVENT (No adverse event) in a 20-month-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AS1412B) for COVID-19 prophylaxis.     No Medical History information was reported.   On 04-Aug-2022 at 4:30 PM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .25 milliliter. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Aug-2022 at 4:30 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (vaccine that underwent temperature excursions could have been administered to patient). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (vaccine that underwent temperature excursions could have been administered to patient) and NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (vaccine that underwent temperature excursions could have been administered to patient), POOR QUALITY PRODUCT ADMINISTERED (vaccine that underwent temperature excursions could have been administered to patient) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for PRODUCT TEMPERATURE EXCURSION ISSUE (vaccine that underwent temperature excursions could have been administered to patient) and POOR QUALITY PRODUCT ADMINISTERED (vaccine that underwent temperature excursions could have been administered to patient).    No concomitant products reported.  It was reported that refrigeration excursions identified, state vaccine was housed in these units. There were excursions noted.The Nurse called for a clinic that she was assisting. The clinic had a similar issue with vaccines stored in their freezer. Vaccines stored in the refrigerator that underwent several temperature excursions going back to August 2022. Date vial moved from freezer to refrigerator was 07-Sep-2022. The vial underwent temperature excursion. The body site was mentioned as deltoid. No adverse reactions reported for the patient.  No treatment products reported.
Pt hospitalized after receiving two series vaccine. Unknown vaccine manufacture or dates. ABD PAIN, NAUSEA AND VOMITING
In first 24 hours, at 03:00 am, I woke up feeling chills and with headache and I got dizzy and feeling weak and tired. My muscles hurt and a body felt very fatigued. Also, a little bit nauseous. I think my fever got to 100 degrees. By noon, I broke my fever. By three pm I was fine again.  The following days, I had soreness at injection site. I had a couple of headaches. There was one  episode where two weeks later, I did get a panic attack and went to urgent care. I went because it lasted longer than normal. This panic attack lasted for 30 minutes that is why I went to Urgent Care. Usually my panic attacks last for 3 minutes - but I also had personal things going on that could have caused it. No treatment, they just said to relax.
Fever, nausea, headache, fatigue, and chills. Treated symptoms with Benadryl and Tylenol
INSOMNIA; FEVER; MUSCLES SORENESS ON THE BACK; FATIGUE; LIGHT HEADACHE; This spontaneous report received from a patient concerned a 69 year old male. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient had no known drug allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 06-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested No concomitant medications were reported.  On 06-APR-2021, the subject experienced insomnia. On 06-APR-2021, the subject experienced fever. On 06-APR-2021, the subject experienced muscles soreness on the back. On 06-APR-2021, the subject experienced fatigue. On 06-APR-2021, the subject experienced light headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from insomnia, fever, and light headache on 06-APR-2021, and had not recovered from fatigue, and muscles soreness on the back. This report was non-serious.
Patient received combination vaccine, Kinrix (DTaP-IPV), at the age of 18 months old. Kinrix is licensed to be given to children between the ages of 4 ? 6yrs of age. No adverse reaction/event reported by patient/guardian at this time.
PATIENT REPORTING: 10/23/2021, day of shot, normal pain at shot location, left arm. Next morning began experiencing intermittent achiness from left shoulder  down to fingertips and up to left temple. Large bruises appeared, one at shot and larger one just below. Intermittent aches from left fingertips to left temple continued until Nov. 2. Symptoms included tingling in fingertips, some numbness, light tension headaches on left side, on and off aches in upper left chest and upper left back. Made doctor's appointment on Monday, Nov. 1; diagnosis was result of vaccination very similar to nerve pain. Prescribed gabapentin 600 mg (starting 1/day for five days, then 2/day for five days, etc.) and prednisone (1/day for six days), began taking Monday night, Nov. 1. On Nov. 2  pain was reducing, and back to normal by Wed. 11/3. AGGRAVATING: arthritis throughout body, including in left shoulder, with ongoing aches there. Shot reaction was decidedly excessive from normal pain
PT IMMEDIATLY HAD BLOODY NOSE FOLLOWING INTRANASAL FLU ADMINISTRATION RESOLVED AFTER APPROX 5 MIN DIRECT PRESSURE.
Approximately 12 hours after the vaccine, the patient developed a rash across the chest which spread to the upper arms, abdomen, and thighs within 24hrs. At the 12hr mark, the patient also developed a crippling migraine, chills, night sweats, and a low-grade fever of 100.1. At 24hrs, significant dyspnea and angina developed which then lasted for approx.. 6 days as well as high fevers with a T-max of 102.5. Patient took aspirin for pain management, which did not help, and then purchased Tylenol for fever.  At 48hrs, the patient developed severe joint pain, which lasted for approx. 9 months post-vaccine. Patient consulted 3 doctors who diagnosed her with polyarthragia and no other known cause for severe joint pain, migraines, and persistent low-grade fevers. Physician prescribed over-the-counter pain medication for management. At approx 11 month mark post-vaccine, the patient remains amenorrheic as is atypical pre-vaccine.
I'm 69 and never really had but a few random minor hot flashes when I experienced menopause at age 50.  However, it isn't on the list of side effects but I've had hot flashes every few hours since about and  2 hours after my first dose injection.  For the most part they are mild but come on every 1 to 4 hours while I'm awake.  I had a terrible one like I'd never had before where I was soaked through my clothes almost exactly 24 hours after the shot the following day.  They are still occurring now 72 hours after the shot.  they are mostly bothersome and will hopefully subside in the next few days.  Other than that I only had the normal local tenderness on my arm.
Vomiting, nausea, chills, fever, and malaise for 12 hours.
Temperature 4 of 5 days, running nose, chest pain, sore throat, cough till today 01/09/18. Temperature from 12/24/17 till 12/29/17. Runny nose, chest pain, cough from 12/24/17 till 01/09/18.
Pulse getting faster, difficult to breathe, lightheaded, dizziness, numbness/tingling on hands and feet. On 23rd, 24th and 25th.
no reaction. vaccine was mixed incorrectly. Diluted with Sterile diluent instead of diluent that comes with vaccine.
Information has been received from a nurse practitioner concerning a 21 year old female who on 27-FEB-2007 and 02-MAY-2007 was vaccinated with her first and second doses of GARDASIL vaccine (yeast) (lots 655619/1427F and 657621/0387U).  There was no concomitant medication.  There was no adverse experience following the first dose.  On 03-MAY-2007, 16 hours after the second dose, the patient experienced flu like symptoms, chills, muscle aches, joint aches, headache, and nausea.  The patient was treated with Tylenol and rest and was recovering, but on 07-MAY-2007 she still reported lethargy and muscle spasms, right arm (injection arm).  Additional information has been requested. This is in follow-up to report(s) previously submitted on 8/14/2007. Information has been received  froma anurse practitioner concerning a 21 year old female (weight 169 #, height 68") who on 27-FEB-2007 was vaccinated with her first dose of GARDASIL vaccine(yeast) (Lot# 655619/1427P). On 03-MAY-2007m at 1 pm, the patient was vaccinated with her second dose of GARDASIL vaccine (yeast) ( Lot #657621/0387U) IM in the right deltois. There was no concomitant medication. There was no adverse experience following the first dose. On  04-MAY-2007 at 4 am, 14 hours after the sceond dose, the patient experienced flu like symptoms. chills,muscle acheesz, joint aches, headache and nausea. Lethargy, malaise and muscle spams in the right arm continued for 4-5 days. The patient was treated with acetaminophen (Tylenol) and rest. ON 07-MAY-2007, the patient still reported lathargy an muscle spasms, right arm (injection arm). On 11-MAY-2007, the patient had recovered from the events. Additional information is not expected
Received Flu Shot (Seasonal- Afluria PF 2009-2010- not 2009 H1N1)in upper left arm.  Moderate pain at the time of injection. Within 1-2 hours onset of SEVERE arm pain- about an 8 on a 1-10 scale (minor localized swelling, no redness) and my range of motion was limited to about 5% of normal. Pain increased throughout the evening and night.  Approximately 40 hours after vaccine, range of motion has improved to about 50%, and pain is rated at about a 4 depending on what position my arm is in.  Treated at home with tylenol and ice at injection site. Please note, if relevant, that I am 17 weeks pregnant. I've had flu and other IM vaccines in the past with no adverse reactions...even while pregnant.
This case was reported by a consumer's spouse and described the occurrence of seizure in a 42-year-old male subject who was vaccinated FLUARIX TRIVALENT or QUADRIVALENT (GlaxoSmithKline), influenza virus vaccine (unspecified). A physician or other health care professional has not verified this report. On 6 January 2014 at 12:00 the subject received a dose of FLUARIX TRIVALENT or QUADRIVALENT (unknown, left deltoid). On 6 January 2014, 3 hours after vaccination with FLUARIX, the subject experienced seizure, fatigue, muscle soreness, body pain, and partial seizure on side. The subject's wife reported that her husband experienced a mild "paraseizure" after being administered the FLUARIX vaccine. She was unsure if the vaccine was trivalent or quadrivalent. The subject's "symptoms originated in his left cheek and extend dose his left arm, mostly in his left thumb and fore fingers". The subject took ibuprofen following FLUARIX vaccination. At the time of the report all his symptoms have remained the same. This case was assessed as medically serious by GSK. At the time of reporting the outcome of the seizure, fatigue, muscle soreness and body pain were unresolved. The spouse also reported that the subject experienced "nothing beyond soreness at the site" with previous flu shots; vaccination dates and details regarding the injection site soreness were not provided. The outcome of the injection site soreness was unspecified.
Pt. stated had blurry vision about 1/2 hr after vaccine. It has not returned to normal. She does state she does get an injection in the eye but hasn't had it since August. Was consulted to contact her eye doctor.
Patient presented with leg pain and shortness of breath to the emergency department.  Was subsequently  found to have a DVT
Information has been received from an office manger concerning a female who in April 2008, was vaccinated with ZOSTER vaccine live (Oka/Merck) and developed a "light rash" post vaccination.  It was unknown if the patient sought medical attention.  Additional information has been requested.
8-10-07 Mother phoned and reported child had "arm band" type swelling around upper left arm, "size of baseball" Denies pain, states is warm to touch. D. Heyer RN
Temperature of 100.4; Headache; Neck pain; back pain; pain with shoulder blades; Tenderness in arm; This is a spontaneous report from a contactable consumer(patient). A 61-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration, administered in Deltoid Left on 04Mar2021 (Batch/Lot Number: EN6205) as Dose 1,Single for COVID-19 immunization. Medical history included Type II diabetic, Adult Asthma. Concomitant Medications included she takes a lot of medications, but does not feel like she needs to list them.  Historical vaccine included for flu shot INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED). No Prior Vaccinations taken within 4 weeks. The patient experienced tenderness in arm on 05Mar2021, headache, neck pain, back pain, pain with shoulder blades on 10Mar2021, temperature of 100.4 on 10Mar2021 17:00.  The patient underwent lab tests and procedures which included body temperature: 100.4 on 10Mar2021. Therapeutic measures were taken. Outcome of the events was tenderness in arm, headache, temperature of 100.4 was recovered on Mar2021.Outcome of the events neck pain, back pain, pain with shoulder blades was recovering.  No follow up attempts are possible. No further information is expected.
States at 1:30am after the vaccination, she woke up with a severe migraine, blurred vision to where she couldn't see, her body had heat wave with the shakes where the inside of her body felt overheated but her outer body was cold. Her vision was so blurry so she laid back down and when she woke up she had fever of 101, her arm where the injection was is super tight, warm and hurts extremely bad so she went to the emergency room on 11/19/20 around 10. When getting the injection she states the nurse stuck her the first time and said she don't want to hurt her and removed that needle and got another needled and re stuck her again.
Injection site became warm, red, itchy and hard. Spot swelled to a size of 8cm X 8cm
MMR received on 6/29/04.  On Monday July 5 my back began to itch.  The itching continued until July 11, no rash was noticed.  I used Hydrocortisone Plus as needed to releive the itching and began to take Benadryl. On Friday July 9, 2004 my lips started to swell and remained swollen until Sunday, July 11.
Pt developed flu symptoms, fever, swollen maxillary B1-lateral glands, fatigue, decrease in appetite, malaise, and joint/muscle aches.
pneumococcal vaccine given 18 days after getting the 2nd dose of the Moderna covid-19 vaccine; This spontaneous case was reported by a consumer and describes the occurrence of PNEUMOCOCCAL IMMUNISATION (pneumococcal vaccine given 18 days after getting the 2nd dose of the Moderna covid-19 vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Arthritis. Concomitant products included PARACETAMOL (TYLENOL) for an unknown indication.   On 22-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-May-2021, the patient experienced PNEUMOCOCCAL IMMUNISATION (pneumococcal vaccine given 18 days after getting the 2nd dose of the Moderna covid-19 vaccine). At the time of the report, PNEUMOCOCCAL IMMUNISATION (pneumococcal vaccine given 18 days after getting the 2nd dose of the Moderna covid-19 vaccine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment details were provided Action taken with mRNA-1273 in response to the events were Not Applicable
Approximately 6 hours after vaccination: felt dizzy and tightness in chest very difficult breathing and a low fever. Took Tylenol pm, next day seemed okay.